# Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/gefitinib-versus-vinorelbine-plus-cisplatin-as-adjuvant-treatment-for-stage-ii-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wen-Zhao Zhong,Qun Wang,Weimin Mao,Lin Xu,Lin Wu,Yucheng Wei,Yong-Yu Liu,Chun Chen,Ying Cheng,Rong Yin,Fan Yang,Shengxiang Ren,Xiaofei Li,Jian Li,Cheng Huang,Zhidong Liu,Shun Xu,Ke‐Neng Chen,Shidong Xu,Lunxu Liu,Ping Yu,Buhai Wang,Haitao Ma,Jin‐Ji Yang,Hong‐Hong Yan,Xue‐Ning Yang,Si‐Yang Liu,Qing Zhou,Yi‐Long Wu |
| Citations | 281 |
| DOI | 10.1200/jco.20.01820 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.01820 |
| OpenAlex ID | https://openalex.org/W3111438285 |
| PMID | 33332190 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Hong‐Hong Yan](https://scholariq.org/researchers/hong-hong-yan/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Lin Wu](https://scholariq.org/researchers/lin-wu/)
- [Qing Zhou](https://scholariq.org/researchers/qing-zhou/)
- [Jin‐Ji Yang](https://scholariq.org/researchers/jin-ji-yang/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.